Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor

(2013) Emily J. Foulstone et al.   ENDOCRINOLOGY

microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1

(2013) Liduan Zheng et al.   PLoS One

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

(2012) Joseph A. Sparano et al.   CANCER

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival

(2012) C. J. Currie et al.   DIABETES CARE

Regulation of glycolysis and the Warburg effect by estrogen-related receptors

(2012) Q Cai et al.   ONCOGENE

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

(2011) J. Stebbing et al.   ANNALS OF ONCOLOGY

Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer

(2011) Emi Tokuda et al.   BREAST CANCER RESEARCH AND TREATMENT

Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer

(2010) L.A. Healy et al.   CLINICAL ONCOLOGY

Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase

(2010) L Zeng et al.   ENDOCRINE-RELATED CANCER

IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin

(2010) Jamie McIntosh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer

(2008) Jennifer K. Litton et al.   JOURNAL OF CLINICAL ONCOLOGY

Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-gallate (EGCG) or an IGF-i receptor inhibitor

(2008) Francis Thomas et al.   PROSTATE